Key result
The Hepcon/HMS instrument displayed satisfactory agreement with anti-Xa plasma heparin concentration (mean bias -0.46 U/mL, limits of agreement +/- 1.12 U/mL) for monitoring heparin levels.
Why the study?
Does the Hepcon/HMS instrument provide satisfactory agreement with laboratory anti-Xa assay for heparin monitoring in adult CPB patients?
Population
42 adult cardiopulmonary bypass (CPB) patients
Comparison
Hepcon/HMS for whole-blood heparin concentration… vs Laboratory anti-factor Xa plasma heparin…
Design
Cross-sectional
Authors
Loading...
Supports Hepcon/HMS for point-of-care heparin monitoring in CPB; leaves open prospective outcome validation before practice change.
Observational (n=42)
Does the Hepcon/HMS instrument provide satisfactory agreement with laboratory anti-Xa assay for heparin monitoring in adult CPB patients?
Mean Difference: -0.46
The Hepcon/HMS instrument displays satisfactory agreement with anti-Xa plasma heparin concentration for clinical use during cardiac surgery.
Raymond et al. (2003) conducted an observational in Cardiopulmonary bypass (n=42). Hepcon/HMS whole-blood heparin concentration vs. Laboratory anti-Xa assay was evaluated on Agreement between Hepcon and anti-Xa heparin (mean bias -0.46 U/mL (limits of agreement +/- 1.12 U/mL)). The Hepcon/HMS instrument displayed satisfactory agreement with anti-Xa plasma heparin concentration (mean bias -0.46 U/mL, limits of agreement +/- 1.12 U/mL) for monitoring heparin levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: